“Advisory Opinion 20-05 on Implementing Allina,” Guidance Portal, U.S. Department of Health & Human Services, December 3, 2020, https://www.hhs.gov/guidance/document/advisory-opinion-20-05-implementing-allina.
Al-Salihi, Kamal, “Keeping it Simple: Finding Falsity Under the False Claims Act,” Whittier Law Review 36 (Spring 2015): 431, 453.
Bohl, Kristin M., et al., Best Practices Handbook for Advising Clients on Fraud and Abuse Issues (Washington, DC: American Health Lawyers Association, 1999).
Centers for Medicare & Medicaid Services, “Chapter 1 - Inpatient Hospital Services Covered Under Part A,” Medicare Benefit Policy Manual, Pub. 100-02, revised March 10, 2017, https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/bp102c01.pdf.
Civil Monetary Penalties Inflation Adjustment, 85 Fed. Reg. 37,004 (June 19, 2020).
“Compliance Guidance,” U.S. Department of Health & Human Services, Office of Inspector General, https://www.oig.hhs.gov/compliance/compliance-guidance/index.asp.
Executive Office of the U.S. President Office of National Drug Control Policy, An Update on the President’s Commission on Combating Drug Addiction and the Opioid Crisis: One Year Later, May 8, 2019, https://trumpwhitehouse.archives.gov/wp-content/uploads/2019/05/Opioid-Commission-Report-One-Year-Later-20190507.pdf.
Fabrikant, Robert, et al., Health Care Fraud: Enforcement and Compliance (New York: ALM, 2021).
Granston, Michael D. “Factors for Evaluating Dismissal Pursuant to 31 U.S.C. 3730(c)(2)(A),” memorandum, January 10, 2018, https://www.insidethefca.com/wp-content/uploads/sites/300/2018/12/Granston-Memo.pdf.
Hooper, Lundy & Bookman, Inc. and Lundy, Jr., Robert W., Treatise on Health Care Law, vol. 1 (Newark: Matthew Bender Elite Products, 2019).
“Maternal Opioid Misuse (MOM) Model,” Centers for Medicare & Medicaid Services, last updated May 4, 2021, https://innovation.cms.gov/innovation-models/maternal-opioid-misuse-model.
“Message from leadership on minimizing burdens on providers,” U.S. Department of Health & Human Services, Office of Inspector General, March 30, 2020, https://oig.hhs.gov/coronavirus/letter-grimm-03302020.asp.
“Patient Driven Payment Model,” Centers for Medicare & Medicaid Services, last modified January 11, 2021, https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/SNFPPS/PDPM.
The President’s Commission on Combating Drug Addiction and the Opioid Crisis, Final Report, November 1, 2017, https://trumpwhitehouse.archives.gov/sites/whitehouse.gov/files/images/Final_Report_Draft_11-15-2017.pdf.
“Self-Disclosure Information,” U.S. Department of Health & Human Services, Office of Inspector General, https://oig.hhs.gov/compliance/self-disclosure-info/index.asp.
“State False Claims Act Reviews,” U.S. Department of Health & Human Services, Office of Inspector General, accessed June 8, 2021, https://oig.hhs.gov/fraud/state-false-claims-act-reviews/.
U.S. Department of Justice, Justice Manual, https://www.justice.gov/jm/justice-manual.
U.S. Department of Justice, “False Claims Act Cases: Government Intervention In Qui Tam (Whistleblower) Suits,” memorandum, June 13, 2012, https://www.justice.gov/sites/default/files/usao-edpa/legacy/2012/06/13/InternetWhistleblower%20update.pdf.
U.S. Department of Justice, The False Claims Act: A Primer, April 22, 2011, https://www.justice.gov/sites/default/files/civil/legacy/2011/04/22/C-FRAUDS_FCA_Primer.pdf.
“Value in Opioid Use Disorder Treatment Demonstration,” Centers for Medicare & Medicaid Services, updated May 6, 2021, https://innovation.cms.gov/innovation-models/value-in-treatment-demonstration.